EUCAST WORKSHOP

1:00pm - 2:00pm AEST | Wednesday, 20th June 2022

* EUCAST update (e.g. changing BPs, the new "I" , BPs in brackets) 

* Anaerobe Susceptibility Testing 

* The Role of Dynamic In Vitro Simulations to Inform Treatment Decisions in UTIs 

View Session Recording

Chair & Speaker | Professor John Turnidge AO

Professor Turnidge graduated in medicine from Sydney University and subsequently trained in infectious diseases and microbiology at Flinders Medical Centre. After a period as Head of Microbiology and Infectious Diseases at Monash Medical Centre in Melbourne, he returned to the Women's and Children's Hospital in Adelaide to a similar position. Subsequently, he became Director of the Division of Laboratory Medicine at the same institution. He has a long-standing interest in antimicrobial prescribing and antimicrobial resistance, and has contributed nationally in these areas to government, international organisations and learned societies, including the NHMRC, the WHO, the US-based Clinical and Laboratory Standards Institute, and the Therapeutic Guidelines-Antibiotic writing group. He co-founded the Australian Society for Antimicrobials, which now has over 800 members. He retains expertise in diagnostic microbiology and infectious diseases clinical work, and his advice is sought on all aspects of antimicrobials from laboratory testing to development and appropriate use. He is currently assisting the Australian Commission on Safety and Quality in Health Care to develop and implement the first comprehensive national surveillance system for antimicrobial use and resistance in Australia. From January 2017, he has taken on the role of Scientific Secretary of the European Committee on Antimicrobial Susceptibility Testing. 

Speaker | Dr. Louise Cooley

Dr Louise Cooley is an infectious diseases physician and clinical microbiologist, and Director of Microbiology and Infectious Diseases at the Royal Hobart Hospital, Tasmania. She is a member of the AGAR Executive Committee, Australian Society for Antimicrobials committee and ASID ICHSIG. Tasmanian representative on the Public Health Laboratory Network and Communicable Diseases Genomics Network, a member of the National Centre for Infections in Cancer (NCIC) and FluCAN research groups. Her clinical and research interests include antimicrobial resistance and surveillance, application of microbial genomics for public health and infection control , epidemiology of influenza, epidemiology and management infections in immunocompromised hosts, and antifungal stewardship in high risk patient groups. 

Speaker | Dr. Iain Abbott

Dr Iain Abbott is an Infectious Diseases Physician and Clinical Microbiologist at The Alfred Hospital, Central Clinical School, Monash University, Melbourne ,Australia. He leads the Pharmacology Research Group within the Department of Infectious Diseases, examining the optimisation of antimicrobials using dynamic antimicrobial PK/PD in vitro models. Iain sits on the Australian National Antimicrobial Susceptibility Testing Committee(AusNAC)and is the scientific editor for the Australian Society for Antimicrobials Breakpoint Newsletter.